FR2781226B1 - 1,4-DIHYDROPYRIDINES WITH CARBONYL BENZODIOXO GROUP - Google Patents

1,4-DIHYDROPYRIDINES WITH CARBONYL BENZODIOXO GROUP

Info

Publication number
FR2781226B1
FR2781226B1 FR9809170A FR9809170A FR2781226B1 FR 2781226 B1 FR2781226 B1 FR 2781226B1 FR 9809170 A FR9809170 A FR 9809170A FR 9809170 A FR9809170 A FR 9809170A FR 2781226 B1 FR2781226 B1 FR 2781226B1
Authority
FR
France
Prior art keywords
benzodioxo
dihydropyridines
carbonyl
group
carbonyl benzodioxo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9809170A
Other languages
French (fr)
Other versions
FR2781226A1 (en
Inventor
Gerard Duret
Gerard Glauert
Andre Pessonnier
Marguerite Henry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon France SAS
Original Assignee
Laboratoire L Lafon SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire L Lafon SA filed Critical Laboratoire L Lafon SA
Priority to FR9809170A priority Critical patent/FR2781226B1/en
Priority to AU46292/99A priority patent/AU4629299A/en
Priority to PCT/FR1999/001749 priority patent/WO2000004015A1/en
Publication of FR2781226A1 publication Critical patent/FR2781226A1/en
Application granted granted Critical
Publication of FR2781226B1 publication Critical patent/FR2781226B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9809170A 1998-07-17 1998-07-17 1,4-DIHYDROPYRIDINES WITH CARBONYL BENZODIOXO GROUP Expired - Fee Related FR2781226B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR9809170A FR2781226B1 (en) 1998-07-17 1998-07-17 1,4-DIHYDROPYRIDINES WITH CARBONYL BENZODIOXO GROUP
AU46292/99A AU4629299A (en) 1998-07-17 1999-07-16 1-4-dihydropyridines with benzodioxo carbonyl group as calcium blockers
PCT/FR1999/001749 WO2000004015A1 (en) 1998-07-17 1999-07-16 1-4-dihydropyridines with benzodioxo carbonyl group as calcium blockers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9809170A FR2781226B1 (en) 1998-07-17 1998-07-17 1,4-DIHYDROPYRIDINES WITH CARBONYL BENZODIOXO GROUP

Publications (2)

Publication Number Publication Date
FR2781226A1 FR2781226A1 (en) 2000-01-21
FR2781226B1 true FR2781226B1 (en) 2000-10-13

Family

ID=9528736

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9809170A Expired - Fee Related FR2781226B1 (en) 1998-07-17 1998-07-17 1,4-DIHYDROPYRIDINES WITH CARBONYL BENZODIOXO GROUP

Country Status (3)

Country Link
AU (1) AU4629299A (en)
FR (1) FR2781226B1 (en)
WO (1) WO2000004015A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2495035C (en) 2002-08-09 2012-02-07 Colgate-Palmolive Company Flexible toothbrush

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2671349B1 (en) * 1991-01-09 1993-04-23 Lafon Labor NOVEL 1,4-DIHYDROPYRIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THERAPEUTIC COMPOSITION CONTAINING THEM.

Also Published As

Publication number Publication date
AU4629299A (en) 2000-02-07
FR2781226A1 (en) 2000-01-21
WO2000004015A1 (en) 2000-01-27

Similar Documents

Publication Publication Date Title
ID29241A (en) TERANELASI KINOLIN DISTRICTS-1,2
DE69933287D1 (en) 12,13-MODIFIED EPOTHILON DERIVATIVES
ID20053A (en) HIPOLIPIDEMAT 1,4-BENZOTIAZEPIN-1,1-DIOXIDE
ATE275151T1 (en) 3,6-KETAL MACROLIDA ANTIBIOTIC
ATE257484T1 (en) 6,9-BRIDGED ERYTHROMYCIN DERIVATIVES
NO20002099D0 (en) 6,11-bridged erythromycin derivative
ID26909A (en) DOWN 1,3,4-OKSADIAZOLON
DE60025958D1 (en) 14,15-BETA-METHYLENE SUBSTITUTED ANDROGENE
DK1149106T3 (en) 4,5-azolo-oxindoles
IT1299338B1 (en) MODULAR STRUCTURE.
DK0898624T3 (en) Clothing for a wide
FR2781226B1 (en) 1,4-DIHYDROPYRIDINES WITH CARBONYL BENZODIOXO GROUP
ID26368A (en) DECREASED 2, HYDROMICIN DEXY
DK1068200T3 (en) 2,4,4-trisubstituted-1,3-dioxolanfungicider
ID24047A (en) TURUNAN 5-SUBSTITUTUS-3-OKSAZIAZOLIL 1,6-NAFTIRIDIN-2 1H-ON
FR2781225B1 (en) 1,4-DIHYDROPYRIDINES WITH CARBONYL PYRIDINE GROUP
FR2781224B1 (en) 1,4-DIHYDROPYRIDINES WITH SULFONAMIDE GROUP
DE29810468U1 (en) post
IT247978Y1 (en) BISCAGLINA WITH MODIFIED STEPS.
IT244821Y1 (en) MODULAR STRUCTURE.
ES1039480Y (en) PERFECTED MODULAR EXHIBITOR.
AU135559S (en) A trellis post
AU135558S (en) A trellis post
FI914474A0 (en) RUNT GAOENDE REKLAMTAVLA.
ES1040318Y (en) PERFECTED EXHIBITOR.

Legal Events

Date Code Title Description
ST Notification of lapse